New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients

New Bladder Cancer Device Clears Tumors In Most Patients, No Surgery Needed

For bladder cancer patients whose tumors stop responding to standard treatment, the choice has often been daunting: undergo radical surgery to remove the entire bladder, or pursue alternative treatments that may not be as effective. The post New Bladder Cancer Device Clears Tumors In Most Patients, No Surgery Needed appeared first on Study Finds.

New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment.

New treatment eliminates bladder cancer in 82% of patients

LOS ANGELES — A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment.  In the majority of cases, the cancer disappeared after only three months of treatment, and almost half the patien...

TAR-200 implant achieves complete remission in 82% of bladder cancer patients

For people facing aggressive bladder cancer that no longer responds to standard treatment, options have often been grim—either undergo life-changing surgery to remove the bladder or try less effective therapies. Now, new research suggests there may be a powerful alternative that could allow many patients to keep their bladder and live cancer-free for years. In a major international clinical trial, an experimental device called TAR-200 achieved c…

Breakthrough Therapy Eradicates Bladder Cancer in 82% of Patients

In a groundbreaking development poised to revolutionize the treatment landscape for bladder cancer, researchers have unveiled TAR-200, an innovative drug-device combination designed to deliver chemotherapy directly into the bladder with unprecedented efficacy. This miniature, pretzel-shaped device encapsulates gemcitabine, a chemotherapy agent, and is introduced into the bladder via a catheter, where it steadily administers the […]